申请人:Hoechst Marion Roussel Deutschland GmbH
公开号:EP0987274A1
公开(公告)日:2000-03-22
The present invention relates to novel compounds, their preparation, their use and pharmaceutical compositions containing the compounds which have a strong antithrombotic effect through reversible inhibition of activated blood coagulation factor VIIa (FVIIa).
本发明涉及新型化合物、其制备方法、用途以及含有这些化合物的药物组合物,这些化合物通过可逆性抑制活化的血液凝固因子 VIIa (FVIIa),具有很强的抗血栓作用。